BEGIN:VCALENDAR
VERSION:2.0
BEGIN:VEVENT
DTSTART:20261114T160000Z
DTEND:20261115T020000Z
LOCATION:
DESCRIPTION:We are organizing a Transplant Symposium on November 14 that will bring together leaders in the field to discuss cutting-edge advances in transplantation. Topics will include emerging biomarkers and diagnostics\, novel therapies for antibody-mediated rejection and tolerance induction\, and the latest developments in xenotransplantation. The program will also highlight innovative bioengineering and targeted therapeutic approaches that are shaping the future of transplant medicine\nRegister for the Symposium\nemail: NephrologyAdmin@mednet.ucla.edu\n\nAgenda\n8:00 – 9:20 AM Breakfast/Registration\nSession I – Novel therapies for Antibody-Mediated Rejection (ABMR)\nModerators: Gabriel Danovitch / Supreet Sethi\n9:20 – 9:30 AM Reza Abdi – Welcome &amp\; Opening\n9:30 – 9:40 AM Kassem Safa “New Frontier in Desensitization: Two patients\, Two therapies.”\n9:40 – 10:05 PM Flavio Vincenti “Targeting Plasma cells and B cells with anti-CD3 iTEs (bi-specific T Cell Engagers) therapies for desensitization”\n10:05 – 10:30 AM Sara Larson “Lessons from B Cell Directed Therapies in Cancer”\n10:30 – 10:55 AM Stanley Jordan “Advances in Prevention &amp\; Treatment of Antibody-Mediated Rejection”\n10:55 – 11:20 AM Georg Böhmig “Targeting antibody- and NK cell-driven kidney transplant rejection”\n11:20 – 11:45 AM Jeff Veale “Delayed Immune Tolerance”\n11:45 – 12:00 PM Panel discussion (15 min)\n12:00 – 1:00 PM Lunch (1 hour)\nSession II – Biomarkers for Kidney Transplant Rejection\nModerators: Julie Yabu / Basmah Abdalla\n1:10 – 1:30 PM Philip Halloran “Molecular phenotyping of transplant rejection and injury”\n1:30 – 1:50 PM Elaine Reed “The role of HLA and non-HLA antibodies in renal transplantation”\n1:50 – 2:10 PM Neal Smith “New Pathology of Cardiac and Renal Antibody-Mediated Rejection”\n2:10 – 2:30 PM Mike Bunnapradist “dd-CFDNA in Kidney Transplant”\n2:30 – 2:40 PM Break (10 min)\nSession III – Xenotransplantation and Tolerance\nModerators: Peter Heeger / Jerzy Kupiec\n2:40 – 3:00 PM David Cooper/Shikhar Tripathi “Xenotransplantation: Lessons and Horizons”\n3:00 – 3:20 PM Michael Curtis “Engineering Hope: Enabling the First Porcine Kidney Transplants in Humans”\n3:20 – 3:40 PM Eckhard Wolf “Genetically modified Auckland Island organ source pigs”\n3:40 – 4:00 PM Leonardo Riella “Clinical Kidney Xenotransplantation: The Massachusetts General Hospital Experience”\n4:00 – 4:20 PM John David Cleveland (USC) “The True potential of Cardiac Xenotransplantation: Two-Year Survival in an Animal Model”\n4:20 – 4:30 PM Panel Discussion (10 min)\nSession IV – Engineering Innovations in Transplantation\nModerators: Andre Nel / Eric Lum\n4:30 – 4:50 PM Reza Abdi “Precision Immune Therapy in Organ Transplantation”\n4:50 – 5:10 PM Zhongwei Li “Kidney Engineering from Human Stem Cells.”\n5:10 – 5:30 PM Abbas Ardehali “The next Chapter in Ex-vivo Heart and lung Perfusion”\n5:30 – 5:50 PM Yangzhi Zhu “Real-Time Biosensing for Organ Transplantation: Assessing Graft Viability During Ex Situ Machine Perfusion”\n5:50 – 5:55 PM Gabriel Danovitch – Closing Remarks (5 min)\nReception/Exhibitor Corner 6:00 pm to 7:30 pm\n\nMeet the Speakers\nReza Abdi\, MD\nProfessor of Medicine\nDirector of Kidney Transplant Immunobiology Program\nUCLA David Geffen School of Medicine\nLos Angeles\, CA\nAbbas Ardehali\, MD\, FACS\nProfessor of Surgery and Medicine at UCLA\nDirector of the Heart\, Lung\, and Heart-Lung Transplant Programs\nDavid Geffen School of Medicine at UCLA\nLos Angeles\, CA\nGeorg A. Böhmig\, MD\nProfessor of Medicine\; Division of Nephrology and Dialysis\,\nMedical University of Vienna\nVienna\, Austria\nSuphamai (Michael) Bunnapradist\, MD\, MS\nProfessor of Clinical Medicine\nDavid Geffen School of Medicine at UCLA\nLos Angeles\, CA\nJohn D. Cleveland\, MD\nAssociate Professor of Clinical Surgery\nProgram Director\, Congenital Cardiac Surgery Fellowship\nAssociate Chief\, Division of Cardiothoracic Surgery\nChildren’s Hospital Los Angeles\nLos Angeles\, CA\nDavid K.C. Cooper\, MD\, PhD\, FRCS\nAdjunct Professor of Surgery\, Thomas E. Starzl\nTransplantation Institute\, University of Pittsburgh Medical Center\nPittsburgh\, PA\nMike Curtis\, PhD\nPresident &amp\; Chief Executive Officer at eGenesis\nPhilip F. Halloran\, MD\, PhD OC\nDirector\, Alberta Transplant Applied Genomics Centre\nProfessor of Medicine\, University of Alberta\,\nEdmonton\, Alberta\, Canada\nStanley Jordan\, MD\nProfessor of Medicine and Pediatrics at\nCedars-Sinai Medical Center\nDirector of Nephrology\, the Kidney Transplant Program\, and the\nHLA and Transplant Immunology Laboratory\nLos Angeles\, CA\nSara Larson\, MD\nAssistant Professor of Medicine\, hematologist-oncologist\nUCLA David Geffen School of Medicine\nLos Angeles\, CA\nZhongwei Li\, PhD\nAssociate Professor\, Medicine\, Stem Cell Biology and\nRegenerative Medicine\nElaine F. Reed\, PhD\nProfessor of Pathology and Laboratory Medicine\nDirector of the UCLA Immunogenetics Center\nDavid Geffen School of Medicine at UCLA\nLos Angeles\, CA\nLeonardo V. Riella\, MD\, PhD\nMedical Director\, Kidney Transplant Program\,\nMassachusetts General Hospital\nAssociate Professor of Medicine\, Harvard Medical School\nBoston\, MA\nKassem Safa\, MD\nAssociate Professor\nMedical Director\, UCLA Kidney Transplant Program\nUCLA David Geffen School of Medicine\nLos Angeles\, CA\nNeal Smith\, MD\, PhD\nAssociate Professor\nClinical and Laboratory Pathology\, Anatomic Pathology\nMass General Brigham\nBoston\, MA\nShikhar Tripathi\, MD\nProfessor\, Department of Hematology\nTransplantation Institute\nPittsburgh\, PA\nJeffrey L. Veale\, MD\nProfessor of Urology at UCLA\nDirector of the UCLA Kidney Transplant Exchange Program\nDavid Geffen School of Medicine at UCLA\nLos Angeles\, CA\nFlavio G. Vincenti\, MD\nClinical Professor of Medicine and Surgery\nEndowed Chair in Kidney Transplantation\nUCSF\nSan Francisco\, CA\nEckhart Wolf\, PhD\nProfessor\nChair of Molecular Animal Breeding and Biotechnology\nGene Center and Department of Veterinary Sciences\nLudwig-Maximilians-Universität München\nMunich\, Germany\nYangzhi Zhu\, PhD\nDirector\, Biomedical Device Center\nAssociate Professor and Core Faculty\,\nTerasaki Institute for Biomedical Innovation\nLos Angeles\, CA\n\nOverview: https://connect.uclahealth.org/dom/event/renal-transplant-symposium/tab/overview/\nFaculty: https://connect.uclahealth.org/dom/event/renal-transplant-symposium/tab/faculty/\nAgenda: https://connect.uclahealth.org/dom/event/renal-transplant-symposium/tab/agenda/\n
SUMMARY:Renal Transplant Symposium
END:VEVENT
END:VCALENDAR